Skip to content
value.today

Abbott Laboratories vs Stratec SE

Add a company

Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.

In short

  • Abbott Laboratories is the larger company by market value: $181.1 B against $571 M for Stratec SE, 317 times as much (market caps of Oct 30, 2026 for Abbott Laboratories and Jan 5, 2024 for Stratec SE). Stratec SE's value is the last on file, from Jan 5, 2024: no market-data feed is connected for its exchange yet.
  • Abbott Laboratories had more revenue: $44.3 B in the year to December 2025 against $302 M for Stratec SE in the year to December 2022.
  • Abbott Laboratories earned more: net income of $6.5 B against $32 M for Stratec SE.
  • Abbott Laboratories keeps more of each dollar of sales: a net margin of 14.7% against 10.6% for Stratec SE.

Market value, the same start = 100

From Jan 2020: how each one's value moved, whatever its size.

0521031552062020202120222023202420252026Abbott Laboratories 119Stratec SE 65

Revenue by fiscal year

US$ billions, as reported in each year's annual results.

$0B$11B$22B$33B$44B201720182019202020212022202320242025Abbott Laboratories $44B

Side by side

Side-by-side comparison; ▲ marks the best value of a measure where higher or lower is better
MeasureAbbott Laboratories
ABT · #117 in the world
Stratec SE
SBS.DE
Profile
Country🇺🇸 USA🇩🇪 Germany
SectorHealthcareHealthcare
IndustryMedical DevicesMedical Devices
Founded1888—
Size
Market cap$181.1 B$571 M*
Revenue$44.3 B$302 M
Net income$6.5 B▲ best$32 M
Employees115,000—
Valuation
P/E ratio38.5×—
Price to sales3.8×—
Price to book3.5×—
Free cash flow yield4.1%—
Profitability
Gross margin56.4%—
Operating margin18.2%—
Net margin14.7%—
Return on equity13.1%—
Return on invested capital11.2%—
Growth
Revenue growth5.7%—
Revenue growth, 3 years a year0.5%—
Earnings per share growth-51.3%—
Financial strength
Debt to equity0.3×—
Cash
Free cash flow margin16.7%—
Shareholder returns
Dividend yield2.3%—
Shareholder yield2.8%—
Strength scores
Piotroski F-score6 of 9—
Altman Z-score zonesafe—
Data as ofMarket cap Oct 2026; ratios FY2025Market cap Jan 2024

▲ marks the better of the two where higher or lower is better; size and valuation multiples are marked for neither

Questions and answers#

Which is bigger, Abbott Laboratories or Stratec SE?

Abbott Laboratories is the larger company by market value: $181.1 B against $571 M for Stratec SE, 317 times as much (market caps of Oct 30, 2026 for Abbott Laboratories and Jan 5, 2024 for Stratec SE). Stratec SE's value is the last on file, from Jan 5, 2024: no market-data feed is connected for its exchange yet.

Which makes more money, Abbott Laboratories or Stratec SE?

Abbott Laboratories had more revenue: $44.3 B in the year to December 2025 against $302 M for Stratec SE in the year to December 2022. Abbott Laboratories earned more: net income of $6.5 B against $32 M for Stratec SE.

Which is more profitable, Abbott Laboratories or Stratec SE?

Abbott Laboratories keeps more of each dollar of sales: a net margin of 14.7% against 10.6% for Stratec SE.

Sources#

Every figure on this page comes from these, with the date shown next to it.